<p>(A) Alveolar macrophages (AM) and NKT were FACS sorted from the lungs at the indicated days and analyzed for IL-33 mRNA via RT-PCR. Cells were pooled from >5 mice for each group at each day. (B) AM were analyzed for intracellular IL-33 protein at 12 d.p.i. in indicated mouse strains. (C) Representative FACS plots of intracellular IL-5 in c-kit<sup>+</sup> ILC2 at 12 d.p.i. after 24 hour <i>ex vivo</i> culture with or without indicated cell depletion. (D) Frequency of IL-5+ c-kit<sup>+</sup> ILC2 at 12 d.p.i. following <i>ex vivo</i> cell depletion after 24 hour culture. Data is representative of 3 experiments with 4–10 mice each. Bars = +/− SEM. **p<.01, ***p<.001.</p
<p>24 hours prior to infection mice were injected with 100 μg of anti NK1.1 antibody i.p. mice were ...
<p>C57BL/6 mice were not infected (NI) or infected with PbA and treated daily with PBS or IL-33 from...
<p>(A) BMDM from C57BL/6 mice were cultured in the lower chamber of a 24-transwell plate in complete...
<p>Lungs from infected CD1d<sup>−/−</sup> or C57BL/6 (WT C57) were harvested at 7 (A–C) and 12 d.p.i...
<p>(A) IL-33 mRNA found in cell populations FACS sorted from the lung at 12 d.p.i.. (B) IL-33 protei...
<p>(A) Representative FACS plots identifying ILC2 in C57BL/6 mice. LIN antibody cocktail included: C...
<p>(A) 1 µg/ml αGC was injected i.p. at 3 and 5 d.p.i.. Lungs were harvested at 7 d.p.i. and total N...
<p>Several signature cytokines in pulmonary ILC (gated as CD45<sup>+</sup>, Lin<sup>-</sup> CD127<su...
<p>TGC-induced peritoneal macrophages derived from B6J-WT mice (A–D) and B6N-WT and -IL-33<sup>−/−</...
<p>(A–D) Rag2<sup>−/−</sup> or C57BL/6 mice were infected with PR8 followed by i.p. injection of 500...
<p>(A) Alveolar macrophages were isolated from untreated WT and <i>Spred-2<sup>−/−</sup></i> mice (n...
<p>(A) Representative plots of CD45<sup>+</sup> lung cells obtained from control B6, DT-treated CCR2...
(A) Treatment scheme for in vivo experiments. (B) Gating strategy to identify ILC2s. They were ident...
<div><p>Respiratory virus infections, such as influenza, typically induce a robust type I (pro-infla...
<p>(A) Identification of live (eFluor780<sup>−</sup>) AM (CD45<sup>+</sup>CD11c<sup>+</sup>Siglec-F<...
<p>24 hours prior to infection mice were injected with 100 μg of anti NK1.1 antibody i.p. mice were ...
<p>C57BL/6 mice were not infected (NI) or infected with PbA and treated daily with PBS or IL-33 from...
<p>(A) BMDM from C57BL/6 mice were cultured in the lower chamber of a 24-transwell plate in complete...
<p>Lungs from infected CD1d<sup>−/−</sup> or C57BL/6 (WT C57) were harvested at 7 (A–C) and 12 d.p.i...
<p>(A) IL-33 mRNA found in cell populations FACS sorted from the lung at 12 d.p.i.. (B) IL-33 protei...
<p>(A) Representative FACS plots identifying ILC2 in C57BL/6 mice. LIN antibody cocktail included: C...
<p>(A) 1 µg/ml αGC was injected i.p. at 3 and 5 d.p.i.. Lungs were harvested at 7 d.p.i. and total N...
<p>Several signature cytokines in pulmonary ILC (gated as CD45<sup>+</sup>, Lin<sup>-</sup> CD127<su...
<p>TGC-induced peritoneal macrophages derived from B6J-WT mice (A–D) and B6N-WT and -IL-33<sup>−/−</...
<p>(A–D) Rag2<sup>−/−</sup> or C57BL/6 mice were infected with PR8 followed by i.p. injection of 500...
<p>(A) Alveolar macrophages were isolated from untreated WT and <i>Spred-2<sup>−/−</sup></i> mice (n...
<p>(A) Representative plots of CD45<sup>+</sup> lung cells obtained from control B6, DT-treated CCR2...
(A) Treatment scheme for in vivo experiments. (B) Gating strategy to identify ILC2s. They were ident...
<div><p>Respiratory virus infections, such as influenza, typically induce a robust type I (pro-infla...
<p>(A) Identification of live (eFluor780<sup>−</sup>) AM (CD45<sup>+</sup>CD11c<sup>+</sup>Siglec-F<...
<p>24 hours prior to infection mice were injected with 100 μg of anti NK1.1 antibody i.p. mice were ...
<p>C57BL/6 mice were not infected (NI) or infected with PbA and treated daily with PBS or IL-33 from...
<p>(A) BMDM from C57BL/6 mice were cultured in the lower chamber of a 24-transwell plate in complete...